arginine-aspartate and Lung-Neoplasms

arginine-aspartate has been researched along with Lung-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for arginine-aspartate and Lung-Neoplasms

ArticleYear
[An antimetastatic study of Arg-Asp (RD) on salivary adenoid cystic carcinoma in vivo].
    Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology, 2002, Volume: 37, Issue:2

    To test the antimetastatic effects of Arg-Asp (RD) on salivary adenoid cystic carcinoma (SACC-LM) in vivo.. RD was administered orally to experimental metastasized nude mice. The pulmonary metastatic foci number and survival were determined to assay the antimetastatic effects of RD.. 30 mg/kg, 120 mg/kg of RD demonstrated an inhibitory effect on the pulmonary metastatic foci formation. All of the tested dosages (7.5 mg/kg, 30 mg/kg, 120 mg/kg) of RD prolonged the survival.. Oral administration of RD has a antimetastatic effect on SACC-LM. RD is low toxicity.

    Topics: Animals; Antineoplastic Agents; Arginine; Aspartic Acid; Carcinoma, Adenoid Cystic; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Salivary Gland Neoplasms

2002